financetom
Business
financetom
/
Business
/
Coupang Shares Fall After Mixed Q1 Results: Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coupang Shares Fall After Mixed Q1 Results: Here's Why
May 8, 2024 11:33 AM

Coupang, Inc. ( CPNG ) shares are trading lower Wednesday after the company posted mixed first-quarter financial results. Here's a look at the key figures from the report. 

The Details:

Coupang ( CPNG ) reported quarterly earnings of 5 cents per share which missed the analyst consensus estimate of 6 cents per share, unchanged from the same period last year. 

Quarterly sales clocked in at $7.11 billion which beat the analyst consensus estimate of $6.91 billion and represents a 22.66% increase over sales of $5.8 billion from the same period last year.

The company said Product Commerce segment net revenues were $6.5 billion, up 15% year-over-year, and Product Commerce active customers reached 21.5 million, growing 16% year-over-year.

"Our results are a reflection of our commitment to customer experience and operational excellence,” said Gaurav Anand, CFO of Coupang ( CPNG ). “We continue to be focused on wowing our customers as we remain just single digit share of a massive and highly fragmented $560 billion commerce opportunity in Korea, and an even smaller share in Taiwan.”

Mizuho analyst James Lee maintained a Neutral rating on Coupang ( CPNG ) and raised the price target from $20 to $23 following the print. 

Related News: Reddit Shares Soar On First Post-IPO Q1 Results, Strong Q2 Guidance

Should I Sell My CPNG Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Shares of Coupang ( CPNG ) have gained 30.34% year to date. This compares to the average annual return of -13.91%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Coupang ( CPNG ) stock currently has an RSI of 72.53, indicating overbought conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

CPNG Price Action: According to Benzinga Pro, Coupang ( CPNG ) shares are down 8.82% at $21.57 at the time of publication Wednesday.

Image: Courtesy of Coupang, Inc. ( CPNG )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Two dozen companies working to find bird flu vaccine for cows, US agriculture secretary says
Two dozen companies working to find bird flu vaccine for cows, US agriculture secretary says
Jun 12, 2024
June 12 (Reuters) - Twenty-four companies are working to develop an avian flu vaccine for cattle, as the virus spreads among U.S. dairy herds, Agriculture Secretary Tom Vilsack told Reuters on Wednesday. Bird flu has infected 90 dairy herds across 12 states since late March, according to the U.S. Department of Agriculture (USDA). Three dairy farm workers also have been...
Pfizer's Duchenne gene therapy fails in late-stage study
Pfizer's Duchenne gene therapy fails in late-stage study
Jun 12, 2024
June 12 (Reuters) - Pfizer ( PFE ) said on Wednesday its experimental gene therapy for Duchenne muscular dystrophy (DMD) failed to improve the motion function of patients in a late-stage trial compared with a placebo. The therapy also did not show a significant difference compared to placebo in secondary goals of the study such the time it takes for...
BRIEF-Integrated Rail And Resources Acquisition Corp. Announces Extension
BRIEF-Integrated Rail And Resources Acquisition Corp. Announces Extension
Jun 12, 2024
Integrated Rail and Resources Acquisition Corp ( IRRX ): * INTEGRATED RAIL AND RESOURCES ACQUISITION CORP. ( IRRX ) ANNOUNCES EXTENSION * INTEGRATED RAIL AND RESOURCES ACQUISITION ( IRRX )- INTENDS TO EXTEND TIME AVAILABLE IN ORDER TO CONSUMMATE A BUSINESS COMBINATION TO JULY 15, 2024 Source text for Eikon: Further company coverage: ...
Australia's Qantas to buy remaining 49% stake in TripADeal
Australia's Qantas to buy remaining 49% stake in TripADeal
Jun 12, 2024
(Reuters) - Australia's Qantas Airways ( QUBSF ) said on Thursday it will acquire the remaining 49% stake in online travel business TripADeal for A$211 million ($140.6 million). ($1 = 1.5011 Australian dollars) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved